Non categorizzato Pfizer to buy Biohaven for $11.6 billion Maggio 10, 2022 0 commenti Pfizer Inc. announced on Tuesday that it is acquiring Biohaven Pharmaceutical Holding Co. Ltd. in a deal worth $11.6 billion or $148.50 per share in cash. Biohaven common shareholders will also receiv… About the author:
Get involved!
Comments